Cost-effectiveness of converting non-sedating antihistamines from prescription to over-the-counter status

10/18/01


Click here to start


Table of Contents

Cost-effectiveness of converting non-sedating antihistamines from prescription to over-the-counter status

Study Purpose

Cost-effectiveness Models

Cost-Effectiveness Model Structure

PPT Slide

PPT Slide

Key Base Case Assumptions

Key Base Case Assumptions

Base Case Results

ICER Sensitivity Analysis: Percent Drop in Non-sedating Price After OTC Conversion

ICER Sensitivity Analysis: Percent of Patients Treated by MD

ICER Sensitivity Analysis: Non-sedating Market Share, Given MD Visit

ICER Sensitivity Analysis: Effect of Rate of Sedation from Sedating Antihistamines

Study Assumptions

Future Analyses

Conclusions

Author: Michael B. Nichol